VRO

New Product Release -- The Pactiv LoadSlammer Accelerates Power Testing by a factor of 200 for AI/ CPU/ FPGA/ Networking Chips

Retrieved on: 
Tuesday, March 19, 2024
2000s, PDN, Capital, Pressure, Software, System, Power Management Bus, TTM, Ecosystem, API, AVS, Multimedia, VRO, OAM

The most advanced chips being introduced to the market today can cost more than $5Bn and many years to develop.

Key Points: 
  • The most advanced chips being introduced to the market today can cost more than $5Bn and many years to develop.
  • Roger Beeston, CEO of ProGrAnalog said, "The Pactiv Solution enables 200x faster validation and testing than conventional Active or Passive testing solutions.
  • The Pactiv LoadSlammer is a 1.5KW transient and/ or continuous power testing solution.
  • Turnkey testing solutions include liquid cooling, TeraDeep Orac Memory and Waveform Controller, Pactiv head unit and all the associated Software.

ObvioHealth and Chemist Warehouse Partner to Power Clinical Trial Efficiency in Australia

Retrieved on: 
Tuesday, November 14, 2023
Research, VRO, Pharmacist, Clinical trial, EMA, Multimedia, Chemist Warehouse, FDA, Prescription, Health, Partnership, Government, Life, Travel, Pharmacy, Pharmaceutical industry

The partnership gives sponsors easier access to a wider pool of participants by driving awareness about trials to Chemist Warehouse's customers in Australia.

Key Points: 
  • The partnership gives sponsors easier access to a wider pool of participants by driving awareness about trials to Chemist Warehouse's customers in Australia.
  • Chemist Warehouse will provide multichannel, targeted communication—including in-store and online touchpoints—to its customer base to promote ObvioHealth-managed trials.
  • This includes informing participants about trials through Chemist Warehouse's range of media assets: a TV show, wellness magazine, and newspaper editorial inserts.
  • In addition to Chemist Warehouse's reach, Australia has seen an increase in trial activity in recent years.

ObvioHealth Strengthens Leadership Team with Key Industry Appointments

Retrieved on: 
Tuesday, October 17, 2023
Multimedia, Acquisition, Drug development, Clinical data management, PRA Health Sciences, King's College, Genetic, Labcorp, Health, Doctor of Philosophy, Parallel, VRO, Cassidy, Growth, Clinical trial, Commercial, United States Department of the Army, Nursing, Science

NEW YORK, Oct. 17, 2023 /PRNewswire/ -- ObvioHealth, a virtual research organization (VRO) delivering stronger clinical evidence through tech-enabled trials, announces the appointment of John Cassidy as its new Chief Financial Officer and Florence Mowlem as Vice President of Science. The two industry veterans will reinforce the company's clinical and digital trial expertise.

Key Points: 
  • The two industry veterans will reinforce the company's clinical and digital trial expertise.
  • At ObvioHealth, he will work alongside the executive team to develop robust financial infrastructure, controls, and planning.
  • Florence Mowlem, Vice President of Science, comes to ObvioHealth from Medable, where she led a team driving the implementation of electronic clinical outcomes assessments (eCOAs).
  • "I hope to help shape the company's scientific strategy to put ObvioHealth at the forefront of life-improving clinical research practices."

ObvioHealth Ranked No. 962 on Inc. 5000's List of Fastest Growing Private Companies

Retrieved on: 
Tuesday, August 15, 2023
Partnership, Oracle Health Sciences, VRO, Pharmaceutical industry

NEW YORK, Aug. 15, 2023 /PRNewswire/ -- Inc. Magazine today ranked ObvioHealth, a global virtual research organization (VRO) pioneering tech-enabled clinical trials, number 962 on its annual list of the nation's fastest-growing private companies. ObvioHealth has now been named on Inc. 5000's premier list for the third consecutive year.

Key Points: 
  • The virtual research organization has been ranked on the list for the third consecutive year.
  • NEW YORK, Aug. 15, 2023 /PRNewswire/ -- Inc. Magazine today ranked ObvioHealth, a global virtual research organization (VRO) pioneering tech-enabled clinical trials, number 962 on its annual list of the nation's fastest-growing private companies.
  • ObvioHealth has now been named on Inc. 5000's premier list for the third consecutive year.
  • Companies on the 2023 Inc. 5000 list are ranked according to percentage revenue growth from 2019 to 2022.

ObvioHealth Signs R&D Partnership with A*STAR to Identify and Develop Novel Digital Biomarkers

Retrieved on: 
Wednesday, May 3, 2023
Clinical Science (journal), SICS, Partnership, Quality of life, Research, Multimedia, Biomarker, Singapore Institute of Technology, Risk, VRO, Medical imaging

A*STAR's SICS aims to identify biomarkers and associated treatments that can help populations manage subclinical symptoms more effectively.

Key Points: 
  • A*STAR's SICS aims to identify biomarkers and associated treatments that can help populations manage subclinical symptoms more effectively.
  • "Many people suffer from health conditions that are not sufficiently severe to be diagnosed using current methods and are therefore not eligible for interventions.
  • We are pleased to collaborate with A*STAR's SICS to develop and validate more sensitive instruments that can bring relief to these populations."
  • The project seeks to identify new digital biomarkers of depressive and anxious feelings, as well as stress, that can be measured and applied in real life settings.

Veeam Releases NEW Veeam Data Platform to Keep Businesses Running as Ransomware Continues to Increase

Retrieved on: 
Tuesday, February 14, 2023
Data Management, Security, Technology, Software, Networks, Internet, Cloud, Software as a service, VRO, VBR, AWS, SLA, Minesweeper, Partnership, VMS, Veeam Backup & Replication, Product management, Smart object, CISO, Ecosystem, Gartner, Organization, Running, Linux, MFA, Microsoft, Face, SWAT, Education minister, ONE, Pure Storage, Environment, Convergent Technologies Operating System, Automation, Azure, RpoS, Premium, Workload, FREE, Salesforce, Product strategy, Senior, Microsoft Azure, New Direction (think tank), Ciox Health, Video game, Risk management, Computer data storage, Cryptocurrency, Physical, Kasten, Kubernetes, Scality, Veeam

The Veeam Data Platform, which includes Veeam Backup & Replication™ (VBR) v12, provides best-in-class secure backup and fast reliable recovery that keeps business running.

Key Points: 
  • The Veeam Data Platform, which includes Veeam Backup & Replication™ (VBR) v12, provides best-in-class secure backup and fast reliable recovery that keeps business running.
  • Veeam Data Platform delivers the three key requirements to keep a business running: data security, data recovery and data freedom to backup and use data from anywhere without platform or cloud lock-in.
  • Platform extensions may be added to any of the Veeam Data Platform editions, or operated standalone, including backup for Kubernetes with Kasten K10 by Veeam , Veeam Backup for Microsoft 365, and Veeam Backup for Salesforce.
  • The NEW Veeam Ransomware Warranty , which complements the Veeam Data Platform, is a commitment to Veeam customers that in the event of a ransomware attack, Veeam will cover the cost of data recovery, up to $5 million dollars.

ObvioHealth and Sterling IRB Partner to Accelerate Access to Clinical Trials

Retrieved on: 
Thursday, February 2, 2023
IRB, Institutional review board, VRO, DCTS, Thought, CNS, Privacy, Institution, DCT, Knowledge, Freedom, Partnership, Pharmaceutical industry, Medical device

NEW YORK, Feb. 2, 2023 /PRNewswire/ -- ObvioHealth and Sterling IRB today announce a partnership to help speed access and adoption of decentralized clinical trials.

Key Points: 
  • NEW YORK, Feb. 2, 2023 /PRNewswire/ -- ObvioHealth and Sterling IRB today announce a partnership to help speed access and adoption of decentralized clinical trials.
  • Sterling IRB will provide its regulatory expertise, paving the way for ObvioHealth's innovative clinical trial designs to gain regulatory approvals.
  • ObvioHealth is a virtual research organization (VRO) that designs and runs tech-enabled clinical trials to reduce patient burden and deliver stronger therapeutic evidence for sponsors.
  • "Sterling IRB and ObvioHealth are like-minded, both sharing a common goal of building stronger DCTs," said Sterling IRB Vice President of Client Services, Institutional Official Kathye Richards.

ObvioHealth and Oracle Collaborate to Seamlessly Integrate Diverse Data Sets Into Decentralized Clinical Trials in APAC

Retrieved on: 
Tuesday, October 25, 2022
Cloud, Guest appearance, Oracle Clinical, APAC, Patient, Multimedia, Collection, VRO, DCT, Industry, Oracle, Oracle Health Sciences, CEO, Environment, EPRO, Heel, DCTS, Oracle Collaboration Suite, Health information management, CRO, Pharmaceutical industry, Online shopping

The alliance will enable the rapid collection, integration and analysis of multi-source data collected from sites, patients, devices and labs.

Key Points: 
  • The alliance will enable the rapid collection, integration and analysis of multi-source data collected from sites, patients, devices and labs.
  • "The Oracle collaboration will allow us to integrate with more complex and diverse data sets."
  • The platform's eConsent, eCOA, and ePRO capabilities will fully integrate into the Oracle Clinical One Cloud Service (Clinical One), facilitating pharma-grade analytics and reporting that can delivermore timely patient insights.
  • Sponsors benefit from the ObvioGo platform's device integrations alongside Oracle Clinical One's robust data management capabilities.

ObvioHealth Announces Innovative Suite of Patient-Centric Tools to Deliver Stronger Clinical Trial Evidence

Retrieved on: 
Thursday, October 13, 2022
Attention, UX, Patient, Multimedia, WhatsApp, Artificial intelligence, VRO, Technology, CEO, View, Clinical trial, EPRO, Digital, WeChat, Solution, Compliance, Medical device, Medical imaging

These patient-centric products and services, deployed through ObvioHealth's powerful ObvioGo platform and app, significantly increase clinical trial compliance and retention while also delivering more accurate and real-time data.

Key Points: 
  • These patient-centric products and services, deployed through ObvioHealth's powerful ObvioGo platform and app, significantly increase clinical trial compliance and retention while also delivering more accurate and real-time data.
  • The ObvioGo patient engagement suite combines four solutions: an intuitively designed mobile app, user-friendly ePRO tools, AI-enabled remote monitoring devices, and virtual one-on-one support.
  • The fourth component of ObvioHealth's patient engagement suite is its COACH (Clinical Oversight and Coordination Hub) team, comprised of clinical trial specialists, registered nurses and principal investigators.
  • Our team is enabled by artificial intelligence, which streamlines their workflows, allowing them to provide high-touch support for a truly differentiating clinical trial journey."

ObvioHealth Introduces ObvioGo, a Next-Generation DCT Platform and Mobile Application Delivering Stronger Evidence

Retrieved on: 
Wednesday, September 14, 2022
Adoption, Safety, Machine learning, BYOD, Guest appearance, RWD, Mobile app, EDC, Compliance, Data management, VRO, Industry, Patient, Clinical trial, DCT, API, EPRO, CEO, Technology, CE, EHR, CTMS, Artificial intelligence, Ecosystem, Caregiver, Biostatistics, Multimedia, Clinical study design, Pharmaceutical industry, Medical imaging, Medical device, Online shopping

NEW YORK, Sept. 14, 2022 /PRNewswire/ -- ObvioHealth, a pioneering virtual research organization (VRO), announces the launch of ObvioGo , a next-generation decentralized clinical trial platform and mobile application powered to deliver stronger evidence of therapeutic efficacy and safety.

Key Points: 
  • NEW YORK, Sept. 14, 2022 /PRNewswire/ -- ObvioHealth, a pioneering virtual research organization (VRO), announces the launch of ObvioGo , a next-generation decentralized clinical trial platform and mobile application powered to deliver stronger evidence of therapeutic efficacy and safety.
  • ObvioGo's powerful and flexible tech stack has been designed to capture and integrate more accurate multi-source data, providing a unified platform thatempowers clinical science teams to generate stronger therapeutic evidence.
  • Mobile Application: ObvioGo's intuitive user interface was designed with extensive insight into the digital behaviors of trial participants.
  • By automating low-value processes, we are enabling humansboth patients and cliniciansto focus on the added value efforts that deliver stronger outcomes."